The post Trump’s Tariffs At Supreme Court Today: What To Know appeared on BitcoinEthereumNews.com. Topline The Supreme Court will hear oral arguments Wednesday on the legality of President Donald Trump’s sweeping “Liberation Day” tariffs, a landmark case that could upend the Trump administration’s signature economic policy, carry millions of dollars in ramifications for businesses and foreign countries and further expand Trump’s executive authority. The Supreme Court will hear oral arguments Wednesday over whether President Donald Trump’s IEEPA tariffs can stand. NurPhoto via Getty Images Key Facts Justices will hear arguments in two cases that challenge Trump’s tariffs, including both the “Liberation Day” tariffs the president imposed on nearly all foreign countries, and the separate tariffs Trump imposed on imports from Canada, Mexico and China due to the trafficking of fentanyl. Trump has imposed his sweeping tariffs under the International Emergency Economic Powers Act (IEEPA), a law that broadly allows presidents to impose economic sanctions during national emergencies. The small businesses and Democratic-led states behind the lawsuits have argued Trump cannot impose his tariffs under IEEPA, arguing the law does not allow the president to impose tariffs and that there’s no national emergency to justify the tariffs even if it did. The Supreme Court will now decide whether the IEEPA-based tariffs can stand, after two lower courts ruled against Trump and said the president does not have authority under IEEPA to impose the tariffs. The case carries huge implications for businesses, who stand to receive refunds on tariffs they’ve already paid if the IEEPA tariffs are struck down, as well as get at least a short-term reprieve from paying tariffs on their imports, and for the Trump administration, which has framed the case as posing an existential threat to the U.S. economy. What To Watch For Justices will hear oral arguments Wednesday, though it’s unclear when their final ruling on the tariffs’ legality will come… The post Trump’s Tariffs At Supreme Court Today: What To Know appeared on BitcoinEthereumNews.com. Topline The Supreme Court will hear oral arguments Wednesday on the legality of President Donald Trump’s sweeping “Liberation Day” tariffs, a landmark case that could upend the Trump administration’s signature economic policy, carry millions of dollars in ramifications for businesses and foreign countries and further expand Trump’s executive authority. The Supreme Court will hear oral arguments Wednesday over whether President Donald Trump’s IEEPA tariffs can stand. NurPhoto via Getty Images Key Facts Justices will hear arguments in two cases that challenge Trump’s tariffs, including both the “Liberation Day” tariffs the president imposed on nearly all foreign countries, and the separate tariffs Trump imposed on imports from Canada, Mexico and China due to the trafficking of fentanyl. Trump has imposed his sweeping tariffs under the International Emergency Economic Powers Act (IEEPA), a law that broadly allows presidents to impose economic sanctions during national emergencies. The small businesses and Democratic-led states behind the lawsuits have argued Trump cannot impose his tariffs under IEEPA, arguing the law does not allow the president to impose tariffs and that there’s no national emergency to justify the tariffs even if it did. The Supreme Court will now decide whether the IEEPA-based tariffs can stand, after two lower courts ruled against Trump and said the president does not have authority under IEEPA to impose the tariffs. The case carries huge implications for businesses, who stand to receive refunds on tariffs they’ve already paid if the IEEPA tariffs are struck down, as well as get at least a short-term reprieve from paying tariffs on their imports, and for the Trump administration, which has framed the case as posing an existential threat to the U.S. economy. What To Watch For Justices will hear oral arguments Wednesday, though it’s unclear when their final ruling on the tariffs’ legality will come…

Trump’s Tariffs At Supreme Court Today: What To Know

Topline

The Supreme Court will hear oral arguments Wednesday on the legality of President Donald Trump’s sweeping “Liberation Day” tariffs, a landmark case that could upend the Trump administration’s signature economic policy, carry millions of dollars in ramifications for businesses and foreign countries and further expand Trump’s executive authority.

The Supreme Court will hear oral arguments Wednesday over whether President Donald Trump’s IEEPA tariffs can stand.

NurPhoto via Getty Images

Key Facts

Justices will hear arguments in two cases that challenge Trump’s tariffs, including both the “Liberation Day” tariffs the president imposed on nearly all foreign countries, and the separate tariffs Trump imposed on imports from Canada, Mexico and China due to the trafficking of fentanyl.

Trump has imposed his sweeping tariffs under the International Emergency Economic Powers Act (IEEPA), a law that broadly allows presidents to impose economic sanctions during national emergencies.

The small businesses and Democratic-led states behind the lawsuits have argued Trump cannot impose his tariffs under IEEPA, arguing the law does not allow the president to impose tariffs and that there’s no national emergency to justify the tariffs even if it did.

The Supreme Court will now decide whether the IEEPA-based tariffs can stand, after two lower courts ruled against Trump and said the president does not have authority under IEEPA to impose the tariffs.

The case carries huge implications for businesses, who stand to receive refunds on tariffs they’ve already paid if the IEEPA tariffs are struck down, as well as get at least a short-term reprieve from paying tariffs on their imports, and for the Trump administration, which has framed the case as posing an existential threat to the U.S. economy.

What To Watch For

Justices will hear oral arguments Wednesday, though it’s unclear when their final ruling on the tariffs’ legality will come out. The Supreme Court typically takes at least a few months to deliberate on cases it hears before issuing a final ruling, but the justices’ willingness to take up the tariff dispute so quickly has raised speculation they could try to rule faster in this case. A decision will come out by June 2026 at the latest, when the court’s term comes to an end.

What Has The Trump Administration Said About The Case?

Trump and his officials have issued dire warnings about the possibility of the Supreme Court overturning the IEEPA tariffs. “I think our country will be immeasurably hurt,” Trump told “60 Minutes” when asked about the possibility the Supreme Court could invalidate his tariffs. “I think our economy will go to hell.” The president has backed down from a previous suggestion that he would attend the oral arguments in person, underscoring how important he believes the case is for his signature economic policy, though Treasury Secretary Scott Bessent is still expected to be present at the Supreme Court on Wednesday. “I am there to emphasize that this is an economic emergency,” Bessent told Fox News on Tuesday about his decision to attend the arguments. “National security is economic security. Economic security is national security. As the Treasury secretary of the United States, I’m in charge of maintaining both.”

What Happens If The Tariffs Get Overturned?

It’s broadly expected the Trump administration will try to impose new tariffs using other laws if the IEEPA ones get struck down, with Bessent telling Reuters this week that businesses and foreign governments “should assume that [the tariffs are] here to stay.” Other legal statutes give presidents more explicit authority to impose tariffs, which Trump has already used to impose tariffs on specific sectors like automobile and steel, but also have more restrictions or take more time to implement. That makes it unclear how long it could take the Trump administration to replace its IEEPA tariffs, and whether any industries now covered by tariffs could be spared in the future, like certain consumer goods. If the Supreme Court rules the IEEPA tariffs are invalid because Trump never had the authority to impose them, businesses that have already paid tariffs under IEEPA are also expected to be entitled to refunds of the tariffs they’ve paid, though trade experts have told Forbes it’s still unclear how any refund process would play out.

Key Background

Trump imposed tariffs on imports from Canada, Mexico and China after taking office before expanding his tariffs in April, announcing “Liberation Day” duties on most imports from nearly all foreign countries. The “Liberation Day” tariffs took full effect in August, after the Trump administration paused the worst of them shortly after they were first rolled out in April and roiled the stock market. The Trump administration has continued to make tariffs the centerpiece of its economic policy despite widespread concerns from economists that the duties will harm the economy and raise prices for consumers, with the federal government raising approximately $195 billion through tariffs during fiscal year 2025, which ended Sept. 30. Small businesses have argued the increased costs from the tariffs pose an existential threat to their ability to operate, bringing lawsuits shortly after Trump first rolled out his tariffs in April. The lawsuits made their way to the Supreme Court after the Court of International Trade and Federal Circuit both ruled against the Trump administration, with justices announcing in September they would make the ultimate decision on the tariffs’ fate.

Further Reading

ForbesSupreme Court Could Overturn Trump’s Tariffs: Target, Samsung, Walmart Would Be Among Biggest WinnersForbesSupreme Court Will Decide Fate Of Trump’s Tariffs—Here’s What Happens If They’re Overturned

Source: https://www.forbes.com/sites/alisondurkee/2025/11/05/supreme-court-will-hear-trump-tariff-case-today-heres-what-to-know/

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$5.33
$5.33$5.33
-1.89%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23